High materiality7/10
Generate Biomedicines price target raised to $30 from $25 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises GENB price target to $30 from $25; current price $15.77.
- Target raised to $30; current price $15.77.
Key facts
- 01
Target: $30
- 02
Posted price: $15.77
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.